Kadenwood, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kadenwood, Inc. - overview
Established
2019
Location
Newport Beach, CA, US
Primary Industry
Consumer Products
About
Kadenwood, Inc. is a US-based company that specializes in premium CBD products, focusing on high-quality formulations for health and wellness applications. Founded in 2019 in Newport Beach, California, Kadenwood, Inc. operates as a leader in the CBD sector, providing high-quality wellness products.
The company has completed 4 deals, with its most recent funding round being a Series B that raised USD 50. 00 mn from investors including Arcadian Capital and The Craftory Limited, bringing the total amount raised to USD 50. 00 mn with a current valuation of USD 181. 518 mn.
Erick Dickens is the current CEO and a co-founder, who has previously been involved in other ventures in the health and wellness space. Kadenwood, Inc. offers a range of premium CBD products designed for health and wellness. Their product line includes tinctures, topicals, and dietary supplements that emphasize quality and efficacy.
Catering to consumers seeking natural health solutions, Kadenwood focuses on creating products that meet rigorous testing standards to ensure safety and effectiveness, appealing to a diverse customer base in the wellness sector. Kadenwood generates revenue through the sale of its CBD products, structured on a model that primarily caters to individual consumers and retailers. The company offers various pricing tiers designed to accommodate the differing needs of health-conscious users, ensuring access to its products for a wide range of consumers. The B2C structure allows Kadenwood to engage directly with end users and establish a loyal customer base.
Kadenwood plans to leverage its recent Series B funding of USD 50. 00 mn, finalized in August 2021, to expand its product offerings and reach new markets. The company is targeting the introduction of innovative health and wellness products within the next year, focusing on enhancing its existing lines to meet consumer demand. Additionally, Kadenwood aims to expand its presence in international markets, particularly in Europe and Asia, by 2023, utilizing its funding to support marketing and distribution efforts that will facilitate this expansion.
Current Investors
Arcadian Capital, The Craftory Limited
Primary Industry
Consumer Products
Sub Industries
Consumer Products, Alternative Medicine
Website
www.kadenwoodbrands.com
Verticals
Cannabis/Medical Marijuana
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.